Letter in response to the Infectious Diseases Society of America's 10 x '20 Initiative
- PMID: 20731568
- DOI: 10.1086/655957
Letter in response to the Infectious Diseases Society of America's 10 x '20 Initiative
Comment on
-
The 10 x '20 Initiative: pursuing a global commitment to develop 10 new antibacterial drugs by 2020.Clin Infect Dis. 2010 Apr 15;50(8):1081-3. doi: 10.1086/652237. Clin Infect Dis. 2010. PMID: 20214473
Similar articles
-
Questions about the 10 x '20 Initiative.Clin Infect Dis. 2010 Sep 15;51(6):751-2; author reply 754-5. doi: 10.1086/655955. Clin Infect Dis. 2010. PMID: 20731566 No abstract available.
-
Development of new antibacterials: a laudable aim, but what is the value?Clin Infect Dis. 2010 Sep 15;51(6):752-3; author reply 754-5. doi: 10.1086/655956. Clin Infect Dis. 2010. PMID: 20731567 No abstract available.
-
Coping with antibiotic resistance: the impending crisis.Int J Antimicrob Agents. 2010 Nov;36 Suppl 3:S1-2. doi: 10.1016/S0924-8579(10)00497-8. Int J Antimicrob Agents. 2010. PMID: 21129626 Review.
-
Antimicrobial resistance: action by laboratories today for a cure tomorrow.Indian J Med Microbiol. 2011 Jul-Sep;29(3):205-6. doi: 10.4103/0255-0857.83899. Indian J Med Microbiol. 2011. PMID: 21860096 No abstract available.
-
A call for antibiotic alternatives research.Trends Microbiol. 2013 Mar;21(3):111-3. doi: 10.1016/j.tim.2012.11.002. Trends Microbiol. 2013. PMID: 23473628 Review.
Cited by
-
Clinical and epidemiological characteristics of multi-drug resistant Enterobacterales isolated from King Fahad Hospital of the University, AlKhobar, Saudi Arabia.J Med Life. 2024 Jan;17(1):41-49. doi: 10.25122/jml-2023-0189. J Med Life. 2024. PMID: 38737657 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical